SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-05-107298
Filing Date
2005-05-13
Accepted
2005-05-13 16:32:38
Documents
5
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.2 TO FORM 10-K d10ka.htm 10-K/A 1582232
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8516
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8525
4 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4698
5 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4721
  Complete submission text file 0001193125-05-107298.txt   1610083
Mailing Address 1600 FARADAY AVE CARLSBAD CA 92008
Business Address 1600 FARADAY AVE CARLSBAD CA 92008 7606037200
INVITROGEN CORP (Filer) CIK: 0001073431 (see all company filings)

IRS No.: 330373077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-25317 | Film No.: 05829792
SIC: 2836 Biological Products, (No Diagnostic Substances)